Harnessing the tissue and plasma lncRNA-peptidome to discover peptide-based cancer biomarkers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Scientific reports. - 9, 1 (2019) , 12322, ISSN: 2045-2322
- Schlagwort
-
Biomarker
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
-
Chakraborty, Sajib
Geoffroy, Andrieux
Hasan, A. M. Mahmudul
Ahmed, Musaddeque
Hosen, Md Ismail
Rahman, Tania
Hossain, Md. Anwar
Börries, Melanie
- DOI
-
10.1038/s41598-019-48774-1
- URN
-
urn:nbn:de:bsz:25-freidok-1508487
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chakraborty, Sajib
- Geoffroy, Andrieux
- Hasan, A. M. Mahmudul
- Ahmed, Musaddeque
- Hosen, Md Ismail
- Rahman, Tania
- Hossain, Md. Anwar
- Börries, Melanie
- Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Blind normalization of public high-throughput databases
Systems medicine in the scope of multi omics analyses
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Understanding the mTOR signaling pathway via mathematical modeling
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Alteration of proteotranscriptomic landscape reveals the transcriptional regulatory circuits controlling key-signaling pathways and metabolic reprogramming during tumor evolution
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Blind normalization of public high-throughput databases
Systems medicine in the scope of multi omics analyses
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Understanding the mTOR signaling pathway via mathematical modeling
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Alteration of proteotranscriptomic landscape reveals the transcriptional regulatory circuits controlling key-signaling pathways and metabolic reprogramming during tumor evolution
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Blind normalization of public high-throughput databases
Systems medicine in the scope of multi omics analyses
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Understanding the mTOR signaling pathway via mathematical modeling
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Alteration of proteotranscriptomic landscape reveals the transcriptional regulatory circuits controlling key-signaling pathways and metabolic reprogramming during tumor evolution